Business

AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review - WSJ

TW

Published by The Wall Street Journal By WSJ · 17 August 2026 at 12:25

AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review - WSJ — Image · The Wall Street Journal

What the report says

Other volrustomig trials would continue as planned, the company said

Read the full report at The Wall Street Journal →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting